Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Vesicles | 4 | 2023 | 42 | 2.410 |
Why?
|
| Ischemia | 6 | 2024 | 243 | 1.620 |
Why?
|
| Retina | 3 | 2021 | 213 | 1.390 |
Why?
|
| Lung Injury | 4 | 2023 | 47 | 1.220 |
Why?
|
| Lung | 12 | 2023 | 1170 | 1.150 |
Why?
|
| Retinal Diseases | 3 | 2023 | 90 | 1.100 |
Why?
|
| Radiation Injuries, Experimental | 3 | 2013 | 41 | 0.960 |
Why?
|
| Ischemic Postconditioning | 2 | 2020 | 10 | 0.900 |
Why?
|
| Culture Media, Conditioned | 2 | 2019 | 104 | 0.800 |
Why?
|
| Beclin-1 | 1 | 2020 | 14 | 0.750 |
Why?
|
| Acute Lung Injury | 4 | 2018 | 60 | 0.730 |
Why?
|
| Retinal Vessels | 2 | 2018 | 58 | 0.720 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2017 | 53 | 0.710 |
Why?
|
| Bone Marrow Cells | 2 | 2017 | 253 | 0.690 |
Why?
|
| Autophagy | 2 | 2020 | 149 | 0.680 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 94 | 0.650 |
Why?
|
| Bleomycin | 2 | 2015 | 98 | 0.640 |
Why?
|
| Sphingosine | 4 | 2013 | 71 | 0.640 |
Why?
|
| MicroRNAs | 1 | 2023 | 534 | 0.630 |
Why?
|
| Lysophospholipids | 3 | 2013 | 63 | 0.610 |
Why?
|
| Retinal Degeneration | 1 | 2017 | 28 | 0.610 |
Why?
|
| Glucose | 1 | 2020 | 638 | 0.600 |
Why?
|
| Radiation Injuries | 2 | 2023 | 155 | 0.550 |
Why?
|
| Rats | 7 | 2023 | 3990 | 0.540 |
Why?
|
| Animals | 26 | 2024 | 26582 | 0.530 |
Why?
|
| Oxygen | 1 | 2020 | 726 | 0.520 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2013 | 2 | 0.470 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 10 | 0.470 |
Why?
|
| Gamma Rays | 1 | 2013 | 72 | 0.470 |
Why?
|
| Sphingolipids | 2 | 2023 | 20 | 0.460 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 41 | 0.460 |
Why?
|
| Retinal Ganglion Cells | 3 | 2024 | 66 | 0.460 |
Why?
|
| Pulmonary Fibrosis | 4 | 2015 | 123 | 0.450 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 388 | 0.440 |
Why?
|
| Receptors, Lysosphingolipid | 4 | 2013 | 36 | 0.410 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 2232 | 0.390 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2010 | 23 | 0.390 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 696 | 0.390 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 1920 | 0.390 |
Why?
|
| Receptors, Opioid, mu | 1 | 2010 | 45 | 0.380 |
Why?
|
| Astrocytes | 2 | 2021 | 139 | 0.370 |
Why?
|
| Simvastatin | 1 | 2010 | 106 | 0.360 |
Why?
|
| Rats, Wistar | 3 | 2020 | 297 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 7 | 2018 | 3092 | 0.350 |
Why?
|
| Mice | 15 | 2024 | 11352 | 0.350 |
Why?
|
| Intravitreal Injections | 2 | 2021 | 67 | 0.350 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 37 | 0.300 |
Why?
|
| Macrophages | 2 | 2007 | 554 | 0.290 |
Why?
|
| Disease Progression | 1 | 2010 | 1531 | 0.280 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 378 | 0.280 |
Why?
|
| Endothelial Cells | 4 | 2023 | 428 | 0.270 |
Why?
|
| Trachea | 1 | 2007 | 293 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 322 | 0.270 |
Why?
|
| Mice, Knockout | 5 | 2013 | 1924 | 0.260 |
Why?
|
| Capillary Permeability | 5 | 2018 | 130 | 0.260 |
Why?
|
| Reperfusion Injury | 2 | 2024 | 131 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2024 | 339 | 0.260 |
Why?
|
| Hypoxia | 2 | 2023 | 641 | 0.250 |
Why?
|
| Epithelial Cells | 2 | 2018 | 669 | 0.250 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2013 | 80 | 0.240 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2013 | 121 | 0.240 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 480 | 0.220 |
Why?
|
| Optic Neuritis | 1 | 2021 | 10 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 1075 | 0.210 |
Why?
|
| Neuromyelitis Optica | 1 | 2021 | 22 | 0.210 |
Why?
|
| Particulate Matter | 2 | 2012 | 79 | 0.200 |
Why?
|
| Cell Line | 3 | 2019 | 2468 | 0.200 |
Why?
|
| Retinal Neurons | 1 | 2021 | 10 | 0.200 |
Why?
|
| Fluorescence | 1 | 2021 | 102 | 0.200 |
Why?
|
| Staining and Labeling | 1 | 2021 | 165 | 0.190 |
Why?
|
| Microglia | 1 | 2021 | 102 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 1219 | 0.190 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2017 | 121 | 0.180 |
Why?
|
| Electroretinography | 2 | 2017 | 76 | 0.180 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2818 | 0.180 |
Why?
|
| Lysosomes | 1 | 2020 | 104 | 0.180 |
Why?
|
| Cell Death | 1 | 2020 | 256 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2018 | 3241 | 0.170 |
Why?
|
| Cytokines | 1 | 2023 | 776 | 0.170 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2018 | 31 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 214 | 0.160 |
Why?
|
| Sulfones | 1 | 2018 | 43 | 0.160 |
Why?
|
| Kinetics | 1 | 2021 | 1513 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 2262 | 0.160 |
Why?
|
| Quinolones | 1 | 2018 | 60 | 0.160 |
Why?
|
| Blood-Retinal Barrier | 1 | 2017 | 4 | 0.150 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 193 | 0.150 |
Why?
|
| Cyclooxygenase 2 | 2 | 2007 | 100 | 0.150 |
Why?
|
| Eye Proteins | 1 | 2018 | 128 | 0.150 |
Why?
|
| Ischemic Preconditioning | 1 | 2016 | 37 | 0.140 |
Why?
|
| Radiation | 1 | 2015 | 15 | 0.140 |
Why?
|
| Aldehyde-Lyases | 1 | 2015 | 15 | 0.140 |
Why?
|
| Free Radical Scavengers | 2 | 2012 | 59 | 0.130 |
Why?
|
| Inflammation | 2 | 2024 | 920 | 0.130 |
Why?
|
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2014 | 4 | 0.130 |
Why?
|
| Acyltransferases | 1 | 2014 | 41 | 0.120 |
Why?
|
| Collagen | 1 | 2015 | 269 | 0.120 |
Why?
|
| Thiophenes | 2 | 2011 | 48 | 0.120 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2014 | 165 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 589 | 0.120 |
Why?
|
| Oxadiazoles | 2 | 2011 | 46 | 0.120 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 8 | 0.120 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 19 | 0.120 |
Why?
|
| Apoptosis | 2 | 2017 | 1683 | 0.120 |
Why?
|
| Propylene Glycols | 1 | 2013 | 30 | 0.120 |
Why?
|
| Humans | 13 | 2023 | 86643 | 0.110 |
Why?
|
| Oxidants | 1 | 2013 | 86 | 0.110 |
Why?
|
| Gene Deletion | 2 | 2011 | 329 | 0.110 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 158 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1578 | 0.110 |
Why?
|
| TRPM Cation Channels | 1 | 2012 | 7 | 0.110 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2012 | 4 | 0.110 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2012 | 14 | 0.110 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 70 | 0.110 |
Why?
|
| Male | 8 | 2020 | 40965 | 0.110 |
Why?
|
| Microvessels | 1 | 2012 | 70 | 0.100 |
Why?
|
| Calpain | 1 | 2012 | 111 | 0.100 |
Why?
|
| Hydrogen Sulfide | 1 | 2012 | 50 | 0.100 |
Why?
|
| Ceramides | 1 | 2011 | 35 | 0.100 |
Why?
|
| Air Pollutants | 1 | 2012 | 78 | 0.100 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 50 | 0.100 |
Why?
|
| Mitochondria | 1 | 2014 | 535 | 0.090 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2010 | 26 | 0.090 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 36 | 0.090 |
Why?
|
| Brain Death | 1 | 2011 | 69 | 0.090 |
Why?
|
| Radiation Pneumonitis | 1 | 2010 | 21 | 0.090 |
Why?
|
| Electric Impedance | 3 | 2018 | 104 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 435 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 82 | 0.090 |
Why?
|
| Blood-Air Barrier | 1 | 2009 | 6 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2013 | 1196 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 458 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 639 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 552 | 0.080 |
Why?
|
| Female | 6 | 2018 | 44532 | 0.080 |
Why?
|
| Aging | 1 | 2013 | 691 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 3 | 2015 | 301 | 0.080 |
Why?
|
| Prostaglandin D2 | 1 | 2007 | 27 | 0.080 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 286 | 0.070 |
Why?
|
| CD11b Antigen | 1 | 2007 | 36 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 71 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2007 | 85 | 0.070 |
Why?
|
| Gene Expression | 2 | 2011 | 1284 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2018 | 1106 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2015 | 712 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2007 | 345 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2007 | 420 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1135 | 0.070 |
Why?
|
| Trans-Activators | 1 | 2007 | 429 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2426 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 645 | 0.060 |
Why?
|
| Reperfusion | 1 | 2024 | 31 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 196 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2007 | 444 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 63 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2023 | 93 | 0.060 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2021 | 9 | 0.050 |
Why?
|
| Pneumonia | 2 | 2013 | 179 | 0.050 |
Why?
|
| Tonometry, Ocular | 1 | 2018 | 10 | 0.040 |
Why?
|
| Biomarkers | 2 | 2014 | 1718 | 0.040 |
Why?
|
| Injections, Intraocular | 1 | 2016 | 5 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 5210 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 217 | 0.040 |
Why?
|
| Smad Proteins | 1 | 2015 | 39 | 0.030 |
Why?
|
| Cardiolipins | 1 | 2014 | 17 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2014 | 307 | 0.030 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2013 | 11 | 0.030 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2013 | 29 | 0.030 |
Why?
|
| Permeability | 1 | 2012 | 137 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2015 | 729 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2012 | 69 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1384 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 236 | 0.030 |
Why?
|
| Thorax | 1 | 2012 | 75 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 125 | 0.030 |
Why?
|
| Receptors, CCR2 | 1 | 2011 | 35 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 192 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1753 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 692 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 503 | 0.020 |
Why?
|
| Drug Inverse Agonism | 1 | 2009 | 3 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2009 | 19 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 371 | 0.020 |
Why?
|
| Body Fluids | 1 | 2009 | 36 | 0.020 |
Why?
|
| Sepsis | 1 | 2013 | 306 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1991 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1673 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 447 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1458 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 172 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1801 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1981 | 0.020 |
Why?
|
| Endotoxins | 1 | 2007 | 36 | 0.020 |
Why?
|
| Calcium | 1 | 2012 | 1156 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 683 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2767 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 408 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1961 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 1456 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 18415 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 25028 | 0.010 |
Why?
|